MedTrace Logo

Bariatric Endoscopy for Treatment of Obesity

NCT04854317 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2025-02-03

No results posted yet for this study

Summary

A single-center, randomized trial will be conducted in order to compare three Endoscopic Gastroplasty (EG) techniques in obese patients (BMI 30-44.99 kg/m2) at Gastroenterology and Gastrointestinal Endoscopy Unit, Mater Olbia Hospital, Qatar Foundation Endowment \& Gemelli Foundation, Italy in period June 2020 - August 2024, with the aim to compare the efficacy and safety of these procedures.

Conditions

Interventions

PROCEDURE

Endoscopic gastroplasty

Endoscopic Gastroplasty

Sponsors & Collaborators

  • Mater Olbia Hospital

    lead OTHER

Principal Investigators

  • Salvatore F. Vadalà di Prampero, MD, PhD · Gastroenterology and GI Endoscopy

  • Milutin Bulajic, MD, PhD · Gastroenterology and GI Endoscopy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04854317 on ClinicalTrials.gov